Chugai Pharma Adopts Lonza’s QC Platform

Chugai Pharmaceutical Manufacturing Co. (CPMC) has adopted Lonza’s Quality Control Microbiology automation platform, MODA-EM, for its environmental and utility monitoring programs. CPMC will use the technology at its Utsunomiya Plant in Japan for capturing, tracking and trending QC Microbiology information. CPMC has completed an eight-month on-site validation of the new system.
 
MODA is a platform for environmental, utility and product monitoring, combining automated scheduling, workflows, mobile data acquisition, device integration, and visual analytics.
 
“We’re excited that CPMC has joined the growing list of global pharmaceutical manufacturers who are raising the standard for QC Micro automation,” said Mike Goetter, global director of Informatics for Lonza Bioscience. “The MODA Platform provides a tangible return on investment for our clients. Delivering on its mission ‘More Science, Less Paper,’ MODA is a defensible monitoring system that stands up to the rigors of compliance standards and audits.”